<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
INTERDEALER QUOTATION SYSTEM
FILED PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934 AND RULE 13A-17
OR 15D-17 THEREUNDER
CYTOGEN CORPORATION
----------------------------------------------
(Exact name of issuer as specified in charter)
600 College Road East, CN 5308, Princeton, New Jersey 08540-5308
----------------------------------------------------------------
(Address of principal executive offices)
Issuer's telephone number, including area code (609) 987-8200
---------------------------------
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of 5% or more in the number of
shares outstanding:
1. Title of Security Common Stock, $0.01 par value per share
- - --------------------------------------------------------------------------------
2. Number of shares outstanding before the change 25,831,016
- - --------------------------------------------------------------------------------
3. Number of shares outstanding after the change 31,453,714
- - --------------------------------------------------------------------------------
4. Effective date of change February 27, 1995
- - --------------------------------------------------------------------------------
5. Method of change:
Specify method (such as merger, acquisition, exchange, distribution, stock
split, reverse split, acquisition of stock for treasury, etc.)
Acquisition
- - --------------------------------------------------------------------------------
Give brief description of transaction Issuance of Common Stock pursuant to
- - --------------------------------------------------------------------------------
Exchange Offer for Units, each Unit consisting of 1.0 share of Callable Common
- - --------------------------------------------------------------------------------
Stock of CytoRad Incorporated and 1.0 warrant to acquire 1.0 share of Common
- - --------------------------------------------------------------------------------
Stock of Cytogen Corporation
- - --------------------------------------------------------------------------------
II. CHANGE IN NAME OF ISSUER
1. Name prior to change
- - --------------------------------------------------------------------------------
2. Name after change
- - --------------------------------------------------------------------------------
3. Effective date of charter amendment changing name
- - --------------------------------------------------------------------------------
4. Date of shareholder approval of change, if required
- - --------------------------------------------------------------------------------
Date March 8, 1995 /s/ T. Jerome Madison
- - --------------------------------------------------------------------------------
(Officer's signature & title)
Name: T. Jerome Madison
Title: Vice President, Chief Financial
Officer and Secretary
